Mrs. Bridget Patricia Kanary, APRN.CNP.15314 Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 27386 Carronade Dr, Perrysburg, OH 43551 Phone: 567-336-4662 |
Sara Jean Hunter, CNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1601 Brigham Dr, Suite 150, Perrysburg, OH 43551 Phone: 419-872-7246 Fax: 419-872-3754 |
Bradley Fox, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1601 Brigham Dr Ste 250, Perrysburg, OH 43551 Phone: 419-872-7745 |
Mrs. Jessica Hartman, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1103 Village Square Dr Ste 100, Perrysburg, OH 43551 Phone: 419-872-3213 Fax: 419-872-9549 |
Mrs. Sarah Boris, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 25660 Dixie Hwy, Perrysburg, OH 43551 Phone: 419-872-5343 Fax: 419-872-7465 |
Samantha Stevenson, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3120 Chappel Dr, Perrysburg, OH 43551 Phone: 567-336-0001 |
Stephanie Lombardo, APRN-CNP Nurse Practitioner - Acute Care Medicare: Medicare Enrolled Practice Location: 1601 Brigham Dr Ste 200, Perrysburg, OH 43551 Phone: 567-585-0380 |
Jennifer Louise Fisher, RN,MS,CFNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1620 Brigham Dr Ste 240, Perrysburg, OH 43551 Phone: 419-872-7700 Fax: 419-874-0196 |
News Archive
Newly created neurons in adults rely on signals from distant brain regions to regulate their maturation and survival before they can communicate with existing neighboring cells - a finding that has important implications for the use of adult neural stem cells to replace brain cells lost by trauma or neurodegeneration, Yale School of Medicine researchers report in The Journal of Neuroscience.
A new study concludes that the POWERWAND peripheral IV (PIV) catheter is an effective alternative to central lines and standard PIV's, achieving unprecedented levels of success in patients requiring longer-term IV therapy.
Alfacell Corporation has announced that the Therapeutic Goods Administration (TGA) in Australia has granted Onconase (ranpirnase) Orphan Drug status for the indication of malignant mesothelioma (MM). Onconase is also designated as an Orphan Drug for MM in Europe.
Scientists at the University of Southampton's Zepler Institute for Photonics and Nanoelectronics are developing a rapid bedside test for diagnosing neonatal Respiratory Distress Syndrome (nRDS) in premature babies.
› Verified 2 days ago